Literature DB >> 27592741

Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach.

Katharina Marie Höflich1, Cordian Beyer1, Tim Clarner1, Christoph Schmitz2, Stella Nyamoya3, Markus Kipp2, Tanja Hochstrasser4.   

Abstract

Axonal damage has been identified as a significant contributor to permanent clinical disability in multiple sclerosis. In the context of demyelinating disorders, this destructive event can be the result of inflammation, demyelination and/or the activation of innate defense cells such as microglia or monocytes. The relative contribution of each of these variables to acute axonal injury is, however, unknown. In the present study, we compared the extent of acute axonal damage in three different murine demyelination models using anti-amyloid precursor protein (APP) immunohistochemistry. T cell dependent (MOG35-55-induced experimental autoimmune encephalomyelitis (EAE)) as well as T cell independent demyelination models (cuprizone- and lysolecithin-induced demyelination) were used. APP+ spheroids were present in all three experimental demyelination models. The number of APP+ spheroids was highest within LPC-induced lesions. Equal amounts were found in the spinal cord of MOG35-55-EAE animals and the corpus callosum of cuprizone-intoxicated animals. Moreover, we detected increased immunoreactivity of the pre-synaptic protein vesicular glutamate transporter 1 (VGluT1) in demyelinated foci. VGluT1-staining revealed long stretched, ovoid-like axonal structures which co-localized with APP. In summary, we showed that acute axonal damage is evident under various experimental demyelination paradigms. Furthermore, disturbed axonal transport mechanisms, which are responsible for intra-axonal APP accumulation, do not only disturb APP, but also the transport of other synaptic proteins. These results indicate that, despite differences in their characteristics, all three models may serve as valid and suitable systems for investigating responsible mechanisms of axonal damage and potential protective strategies.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  APP; Axonal damage; Cuprizone; Experimental autoimmune encephalomyelitis; Lysolecithin

Mesh:

Substances:

Year:  2016        PMID: 27592741     DOI: 10.1016/j.brainres.2016.08.048

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach.

Authors:  Sebastian Rühling; Franziska Kramer; Selina Schmutz; Sandra Amor; Zhan Jiangshan; Christoph Schmitz; Markus Kipp; Tanja Hochstrasser
Journal:  Mol Neurobiol       Date:  2018-09-21       Impact factor: 5.590

2.  A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis.

Authors:  Xiao-Lu Yuan; Yi-Peng Zhao; Jie Huang; Jun-Chen Liu; Wen-Qian Mao; Jun Yin; Bi-Wen Peng; Wan-Hong Liu; Song Han; Xiao-Hua He
Journal:  CNS Neurosci Ther       Date:  2018-03-25       Impact factor: 5.243

3.  Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.

Authors:  Tanja Hochstrasser; Gianna Lisa Exner; Stella Nyamoya; Christoph Schmitz; Markus Kipp
Journal:  J Mol Neurosci       Date:  2017-02-25       Impact factor: 3.444

4.  Neuronal microRNA regulation in Experimental Autoimmune Encephalomyelitis.

Authors:  Camille A Juźwik; Sienna Drake; Marc-André Lécuyer; Radia Marie Johnson; Barbara Morquette; Yang Zhang; Marc Charabati; Selena M Sagan; Amit Bar-Or; Alexandre Prat; Alyson E Fournier
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

5.  Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination.

Authors:  Tanja Hochstrasser; Sebastian Rühling; Kerstin Hecher; Kai H Fabisch; Uta Chrzanowski; Matthias Brendel; Florian Eckenweber; Christian Sacher; Christoph Schmitz; Markus Kipp
Journal:  Cells       Date:  2019-09-03       Impact factor: 6.600

6.  Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.

Authors:  Anne Nack; Matthias Brendel; Julia Nedelcu; Markus Daerr; Stella Nyamoya; Cordian Beyer; Carola Focke; Maximilian Deussing; Chloé Hoornaert; Peter Ponsaerts; Christoph Schmitz; Peter Bartenstein; Axel Rominger; Markus Kipp
Journal:  Cells       Date:  2019-01-28       Impact factor: 6.600

7.  Laquinimod Supports Remyelination in Non-Supportive Environments.

Authors:  Stella Nyamoya; Julia Steinle; Uta Chrzanowski; Joel Kaye; Christoph Schmitz; Cordian Beyer; Markus Kipp
Journal:  Cells       Date:  2019-10-31       Impact factor: 6.600

Review 8.  Regulation and dysregulation of axon infrastructure by myelinating glia.

Authors:  Simon Pan; Jonah R Chan
Journal:  J Cell Biol       Date:  2017-11-07       Impact factor: 10.539

Review 9.  The Cuprizone Model: Dos and Do Nots.

Authors:  Jiangshan Zhan; Teresa Mann; Sarah Joost; Newshan Behrangi; Marcus Frank; Markus Kipp
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

10.  Shikimic Acid Promotes Oligodendrocyte Precursor Cell Differentiation and Accelerates Remyelination in Mice.

Authors:  Fengfeng Lu; Dou Yin; Yingyan Pu; Weili Liu; Zhenghao Li; Qi Shao; Cheng He; Li Cao
Journal:  Neurosci Bull       Date:  2019-01-25       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.